Class Action Lawsuit Alleges Chinese Companies Sold Valsartan Blood Pressure Medication ‘Adulterated’ with Carcinogen
October 12, 2018 Two Chinese companies face a class action over their alleged role in manufacturing and selling adulterated Valsartan, a blood pressure medication.